Fellow Health to Present Nine Studies at the ASRM 2026 Scientific Congress & Expo

Research spans semen quality, fertility preservation, clinical practice patterns, and remote semen testing, including large-scale analyses of data from a network of more than 3,000 fertility and urology practices

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced nine studies to be presented at the American Society for Reproductive Medicine (ASRM) 2026 Scientific Congress & Expo, taking place October 24–28, at the Baltimore Convention Center. The studies draw on data from the company’s nationwide mail-in semen analysis platform, which processes more than 450 patient samples a day.

“Semen analysis has traditionally been used to assess fertility, but it can also tell us a lot about a man’s overall health,” said James F. Smith, MD, MS, Chief Medical Officer and NYS Laboratory Director at Fellow Health. “Because men can collect a sample at home instead of going to a clinic, more of them are able to get tested, which makes access to care more equitable and gives us the scale to study male reproductive health across large populations.”

Presentation Schedule

Oral Presentations

• O-30 — SRBT/SMRU Alliance Survey on Microdissection Testicular Sperm Extraction (microTESE) Practice Patterns: Society for Male Reproduction and Urology (SMRU) Results — Monday, October 26, 12:05–12:15 PM, Room 305
• O-46 — Lower Total Motile Count and Socioeconomic Disadvantage Are Associated with the Number of Semen Samples Provided for Mail-In Sperm Cryopreservation — Monday, October 26, 2:00–2:10 PM, Room 303
• O-47 — Assessing the Impact of Smoking and Vaping on Semen Parameters: A Nationwide Analysis of Men Seeking Fertility Insights — Monday, October 26, 2:10–2:20 PM, Room 303
• O-62 — Social Determinants of Male Fertility: The Impact of Socioeconomic Deprivation on Semen Quality in a Nationwide Cohort — Monday, October 26, 2:30–2:40 PM, Room 305

Poster Presentations

• P-148 — Wildfire Smoke Exposure and Effects on Semen Quality in Men Pursuing Mail-In Semen Analysis Testing in the Contiguous United States — Monday, October 26, 1:30–1:45 PM, Poster Hall Station 13
• P-154 — Cardiometabolic Health and Semen Quality: A Large National Patient-Level Analysis — Monday, October 26, 1:45–2:00 PM, Poster Hall Station 14
• P-317 — Provider Perceptions Regarding Sperm Cryopreservation at an NCI-Designated Cancer Center Without an Oncofertility Program — Tuesday, October 27, 11:15–11:30 AM, Poster Hall Station 11
• P-366 — Validation Is Required for Accuracy of Mail-In Semen Testing: Results of Fellow Health’s Post-Vasectomy Semen Analysis Study — Tuesday, October 27, 1:45–2:00 PM, Poster Hall Station 3
• P-386 — Research Participant Experiences with Remote Semen Sampling — Tuesday, October 27, 1:45–2:00 PM, Poster Hall Station 7

Invited Sessions

Dr. Smith will also speak in two invited sessions:

• SYM-03 — William D. Schlaff, MD, Mentorship and Career Development Symposium The Long Game: Curiosity, Collaboration, and Patient Care — Monday, October 26, 1:45–2:45 PM, Room 321, Baltimore Convention Center
• Case Studies: Funders, Founders, and Clinicians — Thursday, October 29, 10:30 AM–12:00 PM, Baltimore Marriott Inner Harbor at Camden Yards (ASRM INNOVATE)

About Fellow Health

Founded in 2018, Fellow Health is a leading company dedicated to advancing male reproductive health through innovative and comprehensive mail-in testing solutions. The company partners with more than 3,000 fertility and urology practices, processing over 450 patient samples daily through its CLIA-certified lab, and is the leading mail-in semen analysis backed by extensive clinical research demonstrating both accuracy and real-world clinical outcomes, with more than 50 abstracts and peer-reviewed studies supporting its technology and impact. Fellow Health has secured funding from leading life sciences and technology investors, including 5AM Ventures, Forest Road, Labcorp Venture Fund, Human Capital, Genoa Ventures, and Mantis Venture Capital.